Combination therapy with VP16 and ethinylestradiol for hormone-refractory prostate cancer: good response with tolerability.
Year: 2010
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Osaka Medical and Pharmaceutical University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2118387811
